VIRAL MENINGITIS Flashcards

1
Q

Common Causes in Acute Meningitis

A
- Enteroviruses (coxsackieviruses, echoviruses, and human 
enteroviruses 68-71) 
- Varicella-zoster virus 
- Herpes simplex virus 2 
- Epstein-Barr virus 
- Arthropod-borne viruses 
- HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • most common cause of viral meningitis >85% of cases
  • most likely in the summer and fall months (children <15 years)
  • PE: careful search for stigmata of enterovirus infection including exanthems, hand-foot-mouth disease, herpangina, pleurodynia, myopericarditis, and hemorrhagic conjunctivitis.
  • CSF profile: lymphocytic pleocytosis (100-1000 cells/pL), normal glucose and normal or mildly elevated protein concentration.
  • CSF reverse transcriptase PCR (RT-PCR) is the diagnostic procedure of choice
A

Enteroviruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • increasingly recognized as a major cause of viral meningitis in adults
  • second most important cause of viral meningitis 5% of total cases
  • uncomplicated meningitis: ____-2 Herpes simplex virus} - - HSV encephalitis: ____-1 (90%)
  • occurs in ~25-35% of women and ~10-15% of men at the time of an initial (primary) episode of genital herpes.
  • Diagnosis is usually by CSF PCR
A

Herpes simplex virus}

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • Should be suspected in the presence of concurrent chickenpox or shingles
  • The frequency as a cause of meningitis is extremely variable, ranging from as low as 3% to as high as 20% in different series
  • Diagnosis is usually based on CSF PCR
  • Serologic studies complement PCR testing
A

Varicella-zooster virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • May also produce aseptic meningitis, with or without associated infectious mononucleosis.
  • Presence of atypical lymphocytes in the CSF or Peripheral blood
  • Serum and CSF serology - IgM viral capsid antibodies (VCAs), antibodies to early antigens (Eas), and the absence of antibodies to EBV-associated nuclear antigen (EBNA)
A

Epstein-Barr virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • should be suspected in any patient presenting with a viral meningitis with known or suspected risk factors for HIV infection
  • may occur following primary infection with HIV in 5-10% of cases and less commonly at later stages of illness.
  • Cranial nerve palsies (CN: V, Vil, or VIII) are more common in HIV meningitis than in other viral infections
  • Diagnosis can be confirmed by detection of HIV genome in blood or CSF
A

HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • should be considered when meningitis occurs in the late winter or early spring, especially in males. (M:F of 3:1)
  • presence of parotitis, orchitis, oophoritis, pancreatitis, or elevations in serum lipase and amylase is suggestive
  • Diagnosis is typically made by culture of virus from CSF or by detecting IgM antibodies or seroconversion
A

Mumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • be considered when aseptic meningitis occurs in the late fall or winter
  • individuals with a history of exposure to house mice (Mus musculus), pet or Lymphocytic choriomeningitis virus laboratory rodents or their excreta.
  • Lab clues: Presence of leukopenia, thrombocytopenia, or abnormal liver function tests.
  • Diagnosis is based on serology and/or culture of virus from CSF.
A

Lymphocytic choriomeningitis virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CLINICAL MANIFESTATION OF VIRAL MENINGITIS

A
  • Immunocompetent adult patients:
    + Headache
    + Fever
    + signs of meningeal irritation coupled with an inflammatory CSF profile
  • Headache characterized as frontal or retroorbital and frequently associated with photophobia and pain on moving the eyes.
  • Nuchal rigidity is present in most cases
    Constitutional signs: malaise, myalgia, anorexia, nausea and vomiting, abdominal pain, and/or diarrhea.
  • Mild lethargy or drowsiness
  • Profound alterations in consciousness, do not occur, and suggest the presence of encephalitis or other alternative diagnoses.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • most important laboratory test
  • Pleocytosis
  • normal or slightly elevated protein conc. (0.2- 0.8 g/L [20-80 mg/dt])
  • normal glucose conc.
  • Normal or mildly elevated opening pressure (100-350 mmH20)
A

CSF Examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

has become the single most important method for diagnosing CNS viral infections

A

Polymerase Chain Reaction Amplification of Viral Nucleic Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  • Sensitivity is generally poor.

- Specific viruses may also be isolated from throat swabs, stool, blood, and urine.

A

Viral Culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diagnosis of arboviruses such as WNV

A

Serologic Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of almost all cases is primarily symptomatic and includes use of

A
  • analgesic
  • antipyretics
  • antiemetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tx for Seriously ill HSV patients:

A
  • IV acyclovir
  • Acyclovir
  • Famciclover
  • Valacyclovir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patients with HIV meningitis should receive highly active

A
  • antiretroviral therapy
17
Q

is an effective method of preventing the development of meningitis and other neurologic complications associated with poliovirus, mumps, measles, rubella, and varicella infection.

A

Vaccination

18
Q

Common causative organisms: SUBACUTE MENINGITIS

A
  • M Tuberculosis
  • C. neoformans
  • H.capsvlatum-
  • Cimmitis-
  • T. pallidum
19
Q

endemic to the Ohio and Mississippi River valleys of the central United States and to parts of Central and South America

A

H.capsvlatum-

20
Q

endemic to the desert areas of the southwest United States, northern Mexico, and Argentina.

A

Cimmitis-

21
Q

invades the CNS early in the course of syphilis. (CN VII &VIII most frequently involved)

A

T. pallidum-

22
Q

CLINICAL MANIFESTATION SUBACUTE MENINGITIS

A
  • unrelenting headache
  • stiff neck
  • low-grade fever
  • lethargy for days to several weeks
  • Cranial nerve abnormalities and night sweats may be present.
  • This syndrome overlaps that of chronic meningitis
23
Q

Classic CSF abnormalities:

  • elevated opening pressure
  • lymphocytic pleocytosis (10-SOO cells/pL)
  • elevated protein concentration in the range of 1-S 9/L
  • decreased glucose concentration in the range of 1.1-2.2 mmol/L (20-40 mg/dL)
A

Tuberculous Meningitis

24
Q

Combination of unrelenting headache, stiff neck, fatigue, night sweats, and fever witha CSF lymphocytic pleocytosis and a mildly decreased glucose concentration is ___ for tuberculous meningitis.

A

highly suspicious

25
Q

gold standard to make the diagnosis of tuberculous meningitis

A

Culture

26
Q
  • Classic CSF abnormalities:
    1. mononuclear or lymphocytic pleocytosis
    2. increased protein concentration
    3. decreased glucose concentration
  • Eosinophils in the CSF in C immitis meningitis
    Cryptococcal polysaccharide antigen test -highly sensitive and specific
  • CSF complement fixation antibody test - specificity of 100% and a sensitivity of 75% for coccidioidal meningitis.
A

Fungal Meningitis

27
Q
  • Reactive serum treponemal test (fluorescent treponemal antibody absorption test [FTA-ABS] or microhemagglutination assay- T. pallidum[MHA-TP]) with a CSF lymphocytic or mononuclear pleocytosis and an elevated protein concentration
  • CSF Venereal Disease Research Laboratory (VORL) test is positive
A

Syphilitic Meningitis

28
Q

Tx for Tuberculous Meningitis

A

Initial therapy is a combination of:

  • Isoniazid (300 mg/d)
  • Rifampin (10 mg/kg per day)
  • Pyrazinamide (30 mg/kg per day in divided doses)
  • Ethambutol (15-25 mg/kg per day in divided doses) - Pyridoxine (SO mg/d).
29
Q

Tx for Meningitis due to C. neoformans in Non-HIV

Non-Transplant Px

A
  • Induction tx: Amphotericin B IV (0.7 mg/kg/day) + flucytosine for at least 4 wks if CSF culture results are negative after 2 wks of treatment.
  • Extended for a total of 6 weeks in the patient with neurologic complications.
  • Followed by consolidation therapy with fluconazole 400 mg/d for 8 weeks.
30
Q

Tx for Meningitis due to C. neoformans in Non-HIV

Organ Transplant Px

A
  • liposomal AmB or AmB lipid complex (ABLC) + flucytosine for at least 2 wks or until CSF culture is sterile.
  • Follow CSF yeast cultures for sterilization
  • Followed by an 8- to 10-wk course of fluconazole
  • Dose of fluconazole is decreased to 200 mg/d for 6 months toa year If the CSF culture is sterile after 10 weeks of acute therapy.
31
Q

Tx for Meningitis in HIV

A
  • AmB or alipid formulation + flucytosine for at least 2 weeks
  • Followed by fluconazole for a minimum of 8 weeks
  • HIV-infected patients may require indefinite maintenance therapy with fluconazole 200 mg/d.
32
Q

Tx for Meningitis due to H. capsulatum

A
  • AmB (0.7-1.0 mg/kg/day) for 4-12 weeks. Total dose of 30 mg/kg.
  • Maintenance therapy with Itraconazole 200 mg 2-3X daily is initiated and continued for at least 9 mons to a year
33
Q

Tx for Meningitis due to C. immitis

A
  • High-dose fluconazole (1000 mg daily) as monotherapy or IV AmB for >4 weeks.
  • Intrathecal AmB (0.25-0.75 mg/d 3X weekly) may be required to eradicate the infection.
  • Lifelong therapy with fluconazole (200-400 mg daily): prevent relapse
  • AmBisome (S mg/kg per day) or AmB lipid complex (S mg/kg per day) substituted for AmB in patients who have or who develop significant renal dysfunction.
34
Q

Tx for Syphilitic Meningitis

A
  • Aqueous penicillin G in a dose of 3-4 million units IV q4h for 10-14 days.
  • Alternative regimen : 2.4 million units of Procaine Pen G (IM) daily with SOO mg of oral Probenecid 4x daily for 10-14 days.
  • Followed with 2.4 million units of benzathine penicillin G (IM) once a week for 3 weeks.
35
Q

Treatment success criterion

A
  • Reexamination of the CSF
  • CSF should be reexamined at 6-month intervals for 2 years
  • Cell count is expected to normalize within 12 months and VORL titer to decrease by two dilutions or revert to nonreactive within 2 years of completion of therapy